Ingestible Biotelemetry for Adherence

Tiny biodegradable pills that emit a radio signal upon ingestion can report medication use to clinicians in near real‑time. The devices promise to improve adherence tracking for transplants, TB, HIV and other long‑course therapies but raise new issues about consent, data retention, device regulation, reimbursement and coercive uses. — This technology forces debates about medical surveillance, clinician liability, insurance incentives, patient autonomy, and the legal limits on mandated biomedical monitoring.